Channelpedia

Cav1.1 Channel

260 automatically matched literature references

2

Kim H et al. Protein Network Interacting with BK Channels.
Int. Rev. Neurobiol., 2016 , 128 (127-61).

5

Golder FJ et al. Identification and Characterization of GAL-021 as a Novel Breathing Control Modulator.
Anesthesiology, 2015 Nov , 123 (1093-104).

6

Yu L et al. Unoprostone activation of BK (KCa1.1) channel splice variants.
Biochim. Biophys. Acta, 2015 Nov , 1848 (2859-67).

15

Polster A et al. Stac adaptor proteins regulate trafficking and function of muscle and neuronal L-type Ca2+ channels.
Proc. Natl. Acad. Sci. U.S.A., 2015 Jan 13 , 112 (602-6).

20

Wu J et al. Structure of the voltage-gated calcium channel Cav1.1 complex.
Science, 2015 Dec 18 , 350 (aad2395).

23

Cannon SC Channelopathies of skeletal muscle excitability.
Compr Physiol, 2015 Apr , 5 (761-90).

24

Ohrtman JD et al. Apparent lack of physical or functional interaction between CaV1.1 and its distal C terminus.
J. Gen. Physiol., 2015 Apr , 145 (303-14).

26

32

Petkov GV Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2014 Sep 15 , 307 (R571-84).

33

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

34

Stunnenberg BC et al. Cardiac arrhythmias in hypokalemic periodic paralysis: Hypokalemia as only cause?
Muscle Nerve, 2014 Sep , 50 (327-32).

36

38

39

Climent B et al. Effects of obesity on vascular potassium channels.
Curr Vasc Pharmacol, 2014 May , 12 (438-52).

40

Toro L et al. MaxiK channel and cell signalling.
Pflugers Arch., 2014 May , 466 (875-86).

41

Na SJ et al. Whole-genome analysis in Korean patients with autoimmune myasthenia gravis.
Yonsei Med. J., 2014 May , 55 (660-8).

43

Tummala SR et al. Localization of Cacna1s to ON bipolar dendritic tips requires mGluR6-related cascade elements.
Invest. Ophthalmol. Vis. Sci., 2014 Mar , 55 (1483-92).

47

Li HJ et al. Chlorpromazine confers neuroprotection against brain ischemia by activating BKCa channel.
Eur. J. Pharmacol., 2014 Jul 15 , 735 (38-43).

49

Turner RW et al. T-type channels buddy up.
Pflugers Arch., 2014 Jan 11 , ().

51

Sheng J et al. Electrophysiology of human cardiac atrial and ventricular telocytes.
J. Cell. Mol. Med., 2014 Feb , 18 (355-62).

52

Stowell KM DNA testing for malignant hyperthermia: the reality and the dream.
Anesth. Analg., 2014 Feb , 118 (397-406).

56

57

Kunert-Keil CH et al. Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice.
J. Physiol. Pharmacol., 2014 Apr , 65 (317-24).

58

Takacs Z et al. Interaction of the BKCa channel gating ring with dendrotoxins.
Channels (Austin), 2014 , 8 (421-32).

63

Guerrero-Hernández A et al. Ryanodine receptors as leak channels.
Eur. J. Pharmacol., 2013 Nov 28 , ().

64

Gonsalves SG et al. Using exome data to identify malignant hyperthermia susceptibility mutations.
Anesthesiology, 2013 Nov , 119 (1043-53).

67

68

Stoneking CJ et al. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.
Am. J. Physiol., Cell Physiol., 2013 May 1 , 304 (C858-72).

69

Campiglio M et al. Stable incorporation versus dynamic exchange of β subunits in a native Ca2+ channel complex.
J. Cell. Sci., 2013 May 1 , 126 (2092-101).

72

Jorquera G et al. Cav1.1 controls frequency-dependent events regulating adult skeletal muscle plasticity.
J. Cell. Sci., 2013 Mar 1 , 126 (1189-98).

76

Engbers JD et al. Modeling interactions between voltage-gated Ca ( 2+) channels and KCa1.1 channels.
Channels (Austin), 2013 Jul 31 , 7 ().

79

Suzuki Y et al. Direct molecular interaction of caveolin-3 with KCa1.1 channel in living HEK293 cell expression system.
Biochem. Biophys. Res. Commun., 2013 Jan 18 , 430 (1169-74).

82

Wei CJ et al. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis].
Zhonghua Er Ke Za Zhi, 2013 Jan , 51 (47-51).

86

Novaković R et al. The effect of resveratrol on contractility of non-pregnant rat uterus: the contribution of K(+) channels.
J. Physiol. Pharmacol., 2013 Dec , 64 (795-805).

90

Rehak R et al. Low voltage activation of KCa1.1 current by Cav3-KCa1.1 complexes.
PLoS ONE, 2013 , 8 (e61844).

92

Lee EJ et al. Transthyretin is a key regulator of myoblast differentiation.
PLoS ONE, 2013 , 8 (e63627).

99

George AL Leaky channels make weak muscles.
J. Clin. Invest., 2012 Dec 3 , 122 (4333-6).

100

Wu F et al. A calcium channel mutant mouse model of hypokalemic periodic paralysis.
J. Clin. Invest., 2012 Dec 3 , 122 (4580-91).

102

Zhang J et al. Role of the BK channel (KCa1.1) during activation of electrogenic K+ secretion in guinea pig distal colon.
Am. J. Physiol. Gastrointest. Liver Physiol., 2012 Dec 15 , 303 (G1322-34).

104

Song YW et al. Normokalemic periodic paralysis is not a distinct disease.
Muscle Nerve, 2012 Dec , 46 (914-6).

106

Sung CC et al. Genotype and phenotype analysis of patients with sporadic periodic paralysis.
Am. J. Med. Sci., 2012 Apr , 343 (281-5).

109

110

111

Banas K et al. The KATP channel Kir6.2 subunit content is higher in glycolytic than oxidative skeletal muscle fibers.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2011 Oct , 301 (R916-25).

117

Li BY et al. KCa1.1 channel contributes to cell excitability in unmyelinated but not myelinated rat vagal afferents.
Am. J. Physiol., Cell Physiol., 2011 Jun , 300 (C1393-403).

120

He ML et al. Effects of ion channels on proliferation in cultured human cardiac fibroblasts.
J. Mol. Cell. Cardiol., 2011 Aug , 51 (198-206).

122

Stroffekova K The IQ motif is crucial for Cav1.1 function.
J. Biomed. Biotechnol., 2011 , 2011 (504649).

123

Incecik F et al. Hypokalemic periodic paralysis due to the SCN4A R672H mutation in a Turkish family.
Turk. J. Pediatr., 2010 Jul-Aug , 52 (409-10).

124

Raja Rayan DL et al. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.
Curr. Opin. Neurol., 2010 Oct , 23 (466-76).

128

Li J et al. Skeletal phenotype of mice with a null mutation in Cav 1.3 L-type calcium channel.
J Musculoskelet Neuronal Interact, 2010 Jun , 10 (180-7).

131

Sorensen MV et al. Colonic potassium handling.
, 2010 Feb 10 , ().

138

141

Matthews E et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.
Neurology, 2009 May 5 , 72 (1544-7).

142

Harron SA et al. Volume regulation in the human airway epithelial cell line Calu-3.
Can. J. Physiol. Pharmacol., 2009 May , 87 (337-46).

145

Maffè S et al. Atypical arrhythmic complications in familial hypokalemic periodic paralysis.
J Cardiovasc Med (Hagerstown), 2009 Jan , 10 (68-71).

147

Hu H et al. Characterization of ion channels in human preadipocytes.
J. Cell. Physiol., 2009 Feb , 218 (427-35).

149

Poulsen AN et al. Differential expression of BK channel isoforms and beta-subunits in rat neuro-vascular tissues.
Biochim. Biophys. Acta, 2009 Feb , 1788 (380-9).

151

Takacs Z et al. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
Proc. Natl. Acad. Sci. U.S.A., 2009 Dec 29 , 106 (22211-6).

152

Levano S et al. Increasing the number of diagnostic mutations in malignant hyperthermia.
Hum. Mutat., 2009 Apr , 30 (590-8).

153

Carpenter D et al. The role of CACNA1S in predisposition to malignant hyperthermia.
BMC Med. Genet., 2009 , 10 (104).

154

Sørensen MV et al. Aldosterone increases KCa1.1 (BK) channel-mediated colonic K+ secretion.
J. Physiol. (Lond.), 2008 Sep 1 , 586 (4251-64).

157

159

Nakamoto T et al. Apical maxi-K (KCa1.1) channels mediate K+ secretion by the mouse submandibular exocrine gland.
Am. J. Physiol., Cell Physiol., 2008 Mar , 294 (C810-9).

162

Tricarico D et al. Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats.
Neuromuscul. Disord., 2008 Jan , 18 (74-80).

164

Stroffekova K Ca2+/CaM-dependent inactivation of the skeletal muscle L-type Ca2+ channel (Cav1.1).
Pflugers Arch., 2008 Feb , 455 (873-84).

168

Sandoval A et al. gamma1-dependent down-regulation of recombinant voltage-gated Ca2+ channels.
Cell. Mol. Neurobiol., 2007 Nov , 27 (901-8).

169

Houinato D et al. Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family.
Neuromuscul. Disord., 2007 May , 17 (419-22).

171

Kuzmenkin A et al. Gating of the HypoPP-1 mutations: I. Mutant-specific effects and cooperativity.
Pflugers Arch., 2007 Jun , 454 (495-505).

172

Kuzmenkin A et al. Gating of the HypoPP-1 mutations: II. Effects of a calcium-channel agonist BayK 8644.
Pflugers Arch., 2007 Jul , 454 (605-14).

177

Carle T et al. Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis.
Biochem. Biophys. Res. Commun., 2006 Sep 22 , 348 (653-61).

178

Deng XL et al. Properties of ion channels in rabbit mesenchymal stem cells from bone marrow.
Biochem. Biophys. Res. Commun., 2006 Sep 15 , 348 (301-9).

182

183

184

Ke Q et al. [R1239H mutation of CACNA1S gene in a Chinese family with hypokalaemic periodic paralysis]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006 Jun , 23 (272-4).

186

Venance SL et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment.
Brain, 2006 Jan , 129 (8-17).

189

Fang XM et al. Mapping CACNA1S to chromosome 10 in swine using radiation hybrid mapping.
Anim. Genet., 2005 Oct , 36 (437).

190

Vicart S et al. Human skeletal muscle sodium channelopathies.
Neurol. Sci., 2005 Oct , 26 (194-202).

200

Miller TM et al. Correlating phenotype and genotype in the periodic paralyses.
Neurology, 2004 Nov 9 , 63 (1647-55).

203

Links TP et al. [From gene to diseases; hypokalemic periodic paralysis]
, 2004 May 22 , 148 (1035-8).

204

Lunardi J et al. [Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex]
Rev. Neurol. (Paris), 2004 May , 160 (S70-7).

209

Vicart S et al. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis.
Neurology, 2004 Dec 14 , 63 (2120-7).

211

Carsana A et al. Identification of new polymorphisms in the CACNA1S gene.
Clin. Chem. Lab. Med., 2003 Jan , 41 (20-2).

212

Muniz VP et al. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
J. Mol. Neurosci., 2003 , 21 (35-42).

215

Lehmann-Horn F et al. Periodic paralysis: understanding channelopathies.
, 2002 Jan , 2 (61-9).

220

Ikeda Y et al. [Familial hypokalemic periodic paralysis]
, 2001 Nov , 11 (1464-7).

229

232

Bulman DE et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis.
Neurology, 1999 Dec 10 , 53 (1932-6).

234

Lory P et al. [Physiopathology of calcium channels: identification of calcium channelopathies]
C. R. Seances Soc. Biol. Fil., 1998 , 192 (137-47).

236

243

245

246

Iaizzo PA et al. Differential diagnosis of periodic paralysis aided by in vitro myography.
Neuromuscul. Disord., 1995 Mar , 5 (115-24).

250

Plassart E et al. Genetic heterogeneity in hypokalemic periodic paralysis (hypoPP).
Hum. Genet., 1994 Nov , 94 (551-6).

255

Jurkat-Rott K et al. A calcium channel mutation causing hypokalemic periodic paralysis.
Hum. Mol. Genet., 1994 Aug , 3 (1415-9).